BIOATLA, INC. Total Liabilities and Equity
BIOATLA, INC. (BCAB) had Total Liabilities and Equity of $9.51 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $9.51M.
- 2026-03-31: Liabilities and Equity $8.57M.
- 2025-12-31: Liabilities and Equity $13.83M.
- 2025-09-30: Liabilities and Equity $15.91M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $9.51M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.57M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $13.83M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $15.91M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $27.13M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $38.29M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $52.42M 10-K · filed 2026-03-31 |
| 2024-09-30 | $62.24M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $68.64M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $89.20M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $119.66M 10-K · filed 2025-03-28 |
| 2023-09-30 | $151.36M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $179.64M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $204.55M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $225.74M 10-K · filed 2024-03-26 |
| 2022-09-30 | $189.11M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $213.50M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $230.65M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $254.42M 10-K · filed 2023-03-23 |
| 2021-09-30 | $277.58M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $216.71M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $229.09M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $244.94M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |